SLC30A8 and type 2 diabetes mellitus: A coding variant in SLC30A8 was one of the earliest findings of T2D GWAS [71], and the gene immediately piqued research and therapeutic interest: its protein product ZnT8 is expressed mainly in pancreatic islets and transports zinc into insulin-containing granules, thus contributing to insulin processing and storage.